From 1999 to 2005, the use of noninvasive cardiac tests (NCTs), such as stress tests and echocardiography, grew by 57.1%, from 140 to 220 tests per 1000 patient-years, driven almost entirely by increased use of these tests in outpatient clinicians’ offices.1 Concerned that this growth represented unnecessary overuse of testing, starting in 2005 the Centers for Medicare & Medicaid Services (CMS) reduced payments in the provider-based office (PBO) setting by half, from $600 to $300 per test on average. In this issue of JAMA Internal Medicine, Masoudi and colleagues1 investigate how this change in Medicare reimbursement rates for NCTs influenced rates of these tests being performed in hospital-based outpatient (HBO) locations vs PBO locations.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Figueroa JF, Joynt Maddox KE. The Case of Noninvasive Cardiac Testing—For Every Action There Is a Reaction. JAMA Intern Med. 2019;179(12):1706–1707. doi:10.1001/jamainternmed.2019.4265
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: